P1, N=73, Recruiting, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Trial primary completion date: Jul 2023 --> Jul 2024
In summary, SHR0302 in combination with prednisone had a good safety and could achieve a high response for naïve-treatment cGVHD, which suggests that SHR0302 combination might become an optimal choice for naïve-treatment cGVHD.